EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Ca...(futurecapital needs; and risks relating ...),Health

(Date:12/17/2009)... Dec. 17 SpectraScience, Inc., (OTC Bulletin Board: ... Hitchin has issued the following letter to shareholders: ,, ... pleased to announce that through the recent closing of ... undertaking several initiatives critical to ramping our business performance ... additions to our European sales force. We are increasing ...

(Date:12/17/2009)... LOUIS, Dec. 17 Express Scripts, ... the largest pharmacy benefit management companies in ... study that examined the association of seizure ... A-rated anti-epileptic drug formulations. The study found ... drugs, including brand to generic substitution, was ...

(Date:12/17/2009)... RALEIGH, N.C., Dec. 17 Pharmaceutical Institute ... from GeneEd, Inc., a company specializing in life ... advanced e-courses, help expand Pharmaceutical Institute,s already extensive ... Institute is a leading provider of specialized training ... a subsidiary of Campbell Alliance. Financial terms ...

... and RESEARCH TRIANGLE PARK, N.C., Nov. 2 /PRNewswire/,-- ... GSK ),announced today that the U.S. Food and ... for the new drug application for gepirone extended-,release ... with major,depressive disorder. The FDA had previously ...

... Inc.,(Nasdaq: IDMI ) today announced updated results ... trial (DC-MEL-202). The updated results,showed that the investigational ... of immune response and was well tolerated in,patients ... presented during a poster session at the,International Society ...

(Date:12/17/2009)... Good Samaritan Hospital is changing the way ... the launch of the Good Samaritan Hospital Women,s Center ... designed to help treat two common medical problems - ... the bladder, uterus or rectum (pelvic organ prolapse). Three ... leakage and one out of three may experience pelvic ...

(Date:12/17/2009)... National Council on Disability (NCD) will conduct its ... Westheimer, Houston, TX, beginning at 8:30 a.m. on Tuesday, ... Thursday, January 21, 2010. This meeting is open to ... to hear from communities around the country on what ... This meeting will provide another opportunity for that exchange. ...

(Date:12/17/2009)... Data from a recent Thomson Reuters study show that ... papers in 1998 to nearly 112,000 in 2008. ... 2% of the biomedical literature, has evaluated more than ... While only 27 Chinese-authored papers were selected in 2004, ... set to be even higher in 2009. , Jane ...

(Date:12/17/2009)... MA Brandeis University selected Jay and Maureen Neitz, the ... use of gene therapy to treat vision disorders, as ... in Vision Sciences. , The award is funded by ... gift from Brandeis graduates Jay Pepose ,75 and Susan ... graduate research fellowships in vision science. , The Neitzes, ...

(Date:12/17/2009)... The SMARTROLLER®, from OPTP is a uniquely designed, extremely resilient, ... that is flatter and one side that is rounder, making ... , ... Minneapolis, MN (PRWEB) December 17, ... uniquely designed, extremely resilient, ‘two-in-one’ foam roller. This patented foam ...

... vitally important in the fight against HIV and they ... work, according to a new commentary published today in ... Imperial College London, who are evaluating multiple candidate vaccines ... funding agencies must commit to sharing technology and expertise ...

... still do not know what causes epileptic seizures, but ... closer to solving this puzzle with the help of ... is the first human genetic mutation based mouse model ... The mouse is now helping Dr Steven Petrou and ...

... California seniors finds too few health tests , MONDAY, ... received by vulnerable elderly Medicare, Medicaid patients is barely ... at the University of California, Los Angeles, used quality ... Vulnerable Elders project to look at 43 specific types ...

... Quarter of 2007; Company Prepares for ... Integration of Organon BioSciences, KENILWORTH, ... reported financial results for the third,quarter of 2007 and commented ... the Organon human health business,and Intervet animal health business. ...

... settlement agreement with Teva, TOKYO, BRISTOL, ... Inc. ("Astellas"; headquarters: Tokyo; President and CEO: ... and Teva,Pharmaceutical Industries Ltd. ("Teva" Nasdaq: TEVA) ... with Item Development AB ("Item") and,King have ...

... study finds that survival for elderly patients with lung ... expenditures for lung cancer treatment. The study by Harvard ... Research researchers, published in the December 1, 2007 issue ... Society, finds that average life-expectancy rose by less than ...

... a qualitative enzyme immunoassay (EIA) that ... capsid antigen (EBV-VCA), Epstein-Barr early nuclear ... When used in conjunction with Mono-M ... the serodiagnosis of infectious (EBV) mononucleosis ...

... an ELISA method for the qualitative detection of ... (VCA) in human serum. When the VCA IgG ... such as the EBV nuclear antigen (EBNA-1), VCA ... tests, the results can serve as an aid ...

... (Lyme) test is an enzyme ... the qualitative detection of borrelia ... related Borrelia burgdorferi antibodies (IgG, ... in serum as an aid ...

The ImmunoWELL Borrelia (Lyme) Test is an enzyme immunoassay (EIA) for the qualitative and/or semiquantitative detection of Borrelia burgdorferi total antibodies (IgG, IgM, and IgA) in serum and is u...